Akèy › Maladi poumon entèstisyèl › Illinois › Chicago
Etid klinik pou Maladi poumon entèstisyèl nan Chicago, IL
12 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Pulmonary Fibrosis Foundation Community Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Pulmonary Fibrosis Foundation, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Ap rekriteFaz 2/3
- GSK Investigational Site, Chicago
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Ap rekrite
- Northwestern University, Chicago
- University of Illinois Health, Chicago
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Ap rekriteFaz 3
- Northwestern University, Chicago
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Ap rekriteFaz 2
- Clinical Research Site, Chicago
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteEtid obsèvasyon
- Northwestern University, Chicago
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- The University of Chicago Medical Center (UCMC), Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Ap rekriteFaz 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Ap rekriteEtid obsèvasyon
- University of Chicago, Chicago
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Ap rekriteFaz 3
- Northwestern Memorial Hospital, Clinical Research Unit, Chicago
- Rush University Medical Center Outpatient Pulmonary Clinic, Chicago
- UI Health Hospital, Chicago
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of Chicago, Chicago
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Ap rekriteFaz 2
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
Etid Maladi poumon entèstisyèl nan lòt vil
- New York City, NY18 etid
- Philadelphia, PA16 etid
- Los Angeles, CA14 etid
- Kansas City, KS13 etid
- Durham, NC13 etid
- Charleston, SC13 etid
- Houston, TX12 etid
- Ann Arbor, MI11 etid
- Aurora, CO11 etid
- Phoenix, AZ9 etid
- Salt Lake City, UT9 etid
- Boston, MA9 etid
Lòt etid nan Chicago
- Kansè Poumon ki pa ti selil61 etid
- Kansè nan tete58 etid
- Kansè (tout kalite)51 etid
- Kansè Metastatik45 etid
- Kansè pwostat45 etid
- Obèsite41 etid
- Kansè poumon41 etid
- Kansè ovè36 etid
- Akidan serebavaskilè34 etid
- Kansè kolorektal33 etid
- Ensifizyans kadyak31 etid
- Sipwa28 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.